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Abstract 
 Aflatoxin B1 (AFB1) is the most toxic and is usually predominant. Aflatoxins are not only contaminate 
our food stuffs, but also are found in edible tissues, milk and eggs. The present study designated to clarify the 
immunomodulatory effect of vitamin A and if it could ameliorate the cancerous effects of AFB1 on 
histopathological, ultrastucture and immunohistochemical changes of rat colon. Group (I): Animals of this group 
was normal control. Group (II): Rats of this group were orally administered vehicle 50% dimethylsulfoxide. 
While, animals in Group (III) were administered 132 IU Vitamin A, and rats in Group (IV) were administered 
0.05 μg/kg AFB1 dissolved in 50% dimethylsulfoxide for 14 weeks. Group (V): Animals of this group were 
administered AFB1 with Vitamin A.  
AFB1 administration caused colon damage characterized by aberrant crypt foci, which authenticated 
with the increase in mucous production, Bcl-2 and TGF-α expression. The immunological effect of vitamin A 
appeared in the improved histological picture of the colon tissue and the decrease in Bcl-2 and TGF-α 
expression. This is the first study to report the immunomodulatory effect of vitamin A on Bcl-2 and TGF-α in 
AFB1-induced colon cancer.  
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1. Introduction  
 Colon cancer is one of the major causes of cancer death. There is a wide geographic variation in 
incidence, with a 20-fold variance worldwide [1]. Aflatoxins are secondary metabolites produced by Aspergillus 
a widely occurring genus of mold fungi. Food and feed products infested by mold fungi can be contaminated 
with aflatoxins [2]. This is a serious hazard to animal and human health, as aflatoxins are mutagenic and 
carcinogenic. Aflatoxin B1 (AfB1) is the most hazardous mycotoxin in this group, and there is no threshold 
concentration for its toxic effect. AFB1 is classified as a group-1 carcinogen. Since the ingestion of aflatoxins-
contaminated food is associated with several liver diseases [3-5], but is also a colon carcinogen [6]. Several 
factors may enhance the occurrence of mycotoxin in the human diet in developing countries. These include 
eating habits, existing marketing problems which encourage long storage periods; the pre- and post-harvest 
practices that encourage accumulation of moisture and thus mold growth, ignorance, and poverty. This is 
aggravated by the fact that there are no strict regulations that impose limits on the concentration of mycotoxins 
in crops that are marketed in these countries as well as lack of relevant technology required in monitoring fungi 
and mycotoxins in grains [7]. The biological response to AFB1 in terms of genotoxicity and cytotoxicity depends 
on the metabolic formation of AFB1-8,9-epoxide [8], which can covalently bind to nucleic acids or proteins, 
provoking cell membrane damage, necrosis and mutagenesis in the affected cells [9].  
 Apoptosis is the programmed death of cells. It is central to the development and homeostasis of 
multicellular organisms [10], and it is the route by which unwanted or harmful cells are eliminated from the 
organism. Bcl-2 is a family of genes and proteins that govern the MMP. Bcl-2 derives its name from B-cell 
lymphoma 2 which came from being the second member of a range of proteins initially described as a reciprocal 
gene translocation in chromosomes 14 and 18 in follicular lymphomas. The genes and proteins can be either pro-
apoptotic (Bax, BAD, Bak and Bok) or anti-apoptotic (Bcl-2, Bcl-xL, and Bcl-w). These genes interact with the 
Bcl-2 protein structure, which result in either a pro- or anti-apoptosis function. Bcl-2 is involved in a number of 
cancers. These include melanoma, breast, prostate, and lung carcinomas, as reported by Reed et al. [11]. 
 Transforming growth factor alpha (TGF-α) is a polypeptide, which binds to the epidermal growth factor 
receptor to carry out its function related to cell proliferation and differentiation [12]. TGF-α is synthesised as a 
larger precursor of 159 or 160 amino acids, which is an integral membrane glycoprotein (pro TGF-α). The 
mature form is released by proteolytic cleavage of pro TGF-α [13]. Different forms of pro TGF-α have been 
shown to accumulate in the membranes of growth factor producing cell lines.  
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 Vitamin A (vit.A) is significantly prevents aflatoxin-induced damages in the tissue such as liver, kidney 
and gizzard of chicks. Many reports delineated that vit.A is anti-mutagenic, both in vivo and in vitro to prevent 
aflatoxin induced liver damage. Gradelet et al. [14] reported that carotenoids exert their protective effect through 
the deviation of AFB1 metabolism towards detoxication pathways. Carotenoids are also effective in reducing 
DNA damage but less effective than vit. A. However, no data are currently available on the ability of vit. A to 
prevent aflatoxin toxicity in rat colon. Young animals are more susceptible, with the sex and mode of 
administration of the toxin affecting the response. Therefore, this study was designed to evaluate the 
immunomodulatory mechanism of vitamin A to reduce toxicity of aflatoxin B1 in colon of young female rat. 
 
2. Material and Methods 
2.1 Animals and experimental doses: 
 Young female albino Wistar rats weighing 80-100 g, were used in this study. Animals were purchased 
from Animal House, Faculty of Medicine, Ain Shams University. The rats were housed in a room maintained at 
constant humidity (60±5%), temperature (23±1°C), and a 12-h light/dark cycle. The standard diet and tap water 
were available ad libitum throughout the study. After one-week acclimatization period, the animals were 
subsequently divided into five groups of 5 rats each. 
Group (I): Rats of this group kept as normal without any treatment and considered as controls. 
Group (II): Rats belonging to this group were orally administered vehicle 50% dimethylsulfoxide (DMSO). 
Group (III): Animals of this group were orally administered vehicle with Vitamin A (132IU), which is the 
double human therapeutic dose. 
Group (IV): Animals of this group were orally administered 0.05μg/kg AFB1 dissolved in 50% DMSO. 
Group (V): Animals of this group were orally administered 0.05μg/kg AFB1+Vitamin A. 
 The study duration lasted for 14 weeks, the animals were anaesthetized under ether vapor and dissected 
24 hours post treatment. 
2.2 Chemicals: 
 Aflatoxin-B1 were obtained from Sigma Chemical Company (St. Louis, USA). It was dissolved in sun 
oil and orally given at dose 0.05 μg/kg bw/day. Vitamin A is available in market as capsules contain 50000 1U, 
as described by Sinha and Dharmshila [15].The therapeutic dose for rat was calculated according the weigh of 
rats as tabulated by Paget and Barnes [16]. 
2.3 Histological and Electron Microscope Preparations: 
 Pieces of colon were immediately removed after sacrifice, fixed in 10% formalin solution, dehydrated 
in ascending series of alcohol, cleared in xylene and finally embedded in paraffin wax. Sections of 4 mm 
thickness were cut using rotary microtome and mounted on clean slides, for histological examination sections 
were stained with haematoxylin and eosin according to [17]. For electron microscopic studies, fresh small pieces 
of  colon were fixed in 3% glutaraldhyde-formalhyde for 5 h. then in (0.2 M) Na cacodylate for 2h. at 4°C, then 
washed in phosphate buffer pH. 7.2 for 30 min. and post fixed in 1% osmic acid (2% OsO4+ 0.3 M of Na 
cacodylate) for 2 h. at 4°C. Then tissue pieces washed in phosphate buffer (pH 7.2) for 30 min. at 4°C. Samples 
were dehydrated through ascending grades of ethanol and embedded in epoxy resin in an oven at 60°C for 14 h. 
to produce a firm block. Ultrathin sections about 80 nm thickness with ultramicrotome, stained with uranyl 
acetate and lead citrate were finally examined by Transmission E.M. JOEL 1200 EX II at the Central Lab., 
Faculty of Science, Ain Shams University. 
 
2.4 Histochemical Investigations: 
Colon tissue slides were stained with Alcian blue P.A.S technique [18] for distinguishing between acid 
and neutral mucins. The rationale of the method is that acid mucins stain first with alcian blue and are unable to 
react with the subsequent P.A.S. Following on with P.A.S., only neutral mucins and carbohydrates such as 
glycogen will stain red. 
2.5 Immunohistochemistry Detection: 
 Immunohistochemistry is the process of localizing proteins in tissues by exploiting the principle of 
antibodies binding specifically to antigens. The visualization of the antibody is commonly accomplished by 
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conjugating an enzyme to the antibody. This can produce a color changing reaction. The advantage of this 
method is the ability to show exactly where a given protein is located. The expression of Bcl-2 and TGF-α in 
colon tissue was determined immunohistochemically in formalin-fixed, paraffin-embedded tissue blocks were 
cut into 4 mm thick sections mounted on glass slides, and then kept in an oven at 4°C overnight. Sections were 
deparaffinized in xylene and rehydrated. Endogenous peroxidase activity was blocked with 1% hydrogen 
peroxide for 20 min. To improve the quality of staining, microwave oven-based antigen retrieval was performed. 
Slides were probed with either anti-Bcl-2 (1:100, mouse mAb) or anti-TGF-α (1:100, mouse mAb). Sections 
were washed with PBS for 10 min each and incubated with biotin-labeled anti-mouse IgG for 1 h at room 
temperature. After washing, sections were stained with a streptavidin-peroxidase detection system.  
 
3. Results 
3.1 Histopathological Observations: 
 Sections of colon of control rat revealed the luminal surface is lined by simple columnar cells with basal 
oval nuclei and apical brush border. Goblet cells predominate in the glands characterized by mucous granules 
occupying the apical two thirds of the cell. The nucleus is located in the basal region of the cell. The bases of the 
crypts are lined by columnar cells with basal and oval vesicular nuclei   (Figure 1). Colon sections of rats treated 
with vehicle and from rats treated with Vit. A showed normal crypt lined with columnar cells with basal nuclei, 
few goblet cells and normal arrangement of fibrils of muscularis mucosa (Figures 2 & 3).  
 Colonic sections from rats treated with AFB1 showing many deleterious effect such as well 
differentiated clusters of abnormal tube-like glands in the lining of the colon (called tubular adenocarcinoma) 
and there is a strong relationship between the number of aberrant foci crypt and increased goblet cells (Figure 4), 
larger aberrant crypts consisted of five crypts stained more darkly with thicker epithelial lining than normal 
crypts and each lumen was compressed or not distinct (Figure 5). Section of colon showed also differentiated 
adenocarcinoma and increased mitotic activity among lymphocytes in the lamina propria (Figure 6), abnormal 
foci consisted of ten crypts with numerous goblet cells and lymphocytes infiltration as appeared in Figure (7). 
 Colonic sections of rats treated daily with AFB1+Vit. A showed the luminal surface lined by simple 
columnar cells with brush borders and basal oval nuclei. The bases of the crypts lined by columnar cells with 
basal and goblet cells and the muscularis mucosa showed dettachment (Figure 8), near to normal arrangement of 
the colonic crypts (Figure 9), closely packed simple tubular colonic crypts extending down to muscularis mucosa 
(Figure 10), more or less crypt normal, lymphocytes infiltration in the lamina propria (Figure 11). 
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Figure 1: Photomicrograph of colon cross 
section of control rat showing the luminal 
surface is lined by simple columnar cells 
(arrow) with basal oval nuclei and apical brush 
border. Goblet cells (G) predominate in the 
glands characterized by mucous granules 
occupying the apical two thirds of the cell. The 
nucleus is located in the basal region of the 
cell. The bases of the crypts are lined by 
columnar cells with basal and oval vesicular 
nuclei (H-E, X400).  
Figure 2: Photomicrograph from cross section 
of colon from rat treated with DSMO normal 
crypt lined with columnar cells with basal 
nuclei and normal arrangement of fibrils of 
muscularis mucosa (M) (H-E, X400). 
Figure 3: Photomicrograph of colon cross 
section from rat treated with vit. A showing 
normal histological structure of the colonic 
crypt with few goblet cells (G) (H-E, X400). 
 
 
Figure 4: Photomicrograph from cross section 
of colon from AFB1 treated rat showing well 
differentiated tubular adenocarcinoma and 
there is a strong relationship between the 
number of AFC and increased goblet cells (G). 
(H-E, X 400). 
Figure 5: Photomicrograph from cross section 
of colon from AFB1 treated rat showing larger 
aberrant crypts consisting of 5 crypts 
(surrounded by line) stained more darkly with 
thicker epithelial lining than normal crypts and 
each lumen was compressed or not distinct. (H-
E, X400). 
Figure 6: Photomicrograph from cross section 
of colon AFB1 treated rat showing 
differentiated adenocarcinoma, goblet cell (G) 
hyperplasia and increased mitotic activity 
(arrows) among lymphocytes in the lamina 
propria. (H-E, X400). 
Figure 7: Photomicrograph from cross section 
of colon AFB1 treated rat showing abnormal 
foci consisted of 10 crypts (surrounded by line) 
with numerous goblet cells (G), lymphocytes 
infiltration (*). (H-E, X 400). 
 
Journal of Natural Sciences Research                                                                                                 www.iiste.org 
ISSN 2224-3186 (Paper)   ISSN 2225-0921 (Online) 
Vol.3, No.5, 2013 
 
71 
 
 
Figure 8: Photomicrograph from colon section 
from rat treated with AFB1+Vit.A showing the 
luminal surface is lined by simple columnar 
cells with apical brush borders and basal oval 
nuclei (arrow). The bases of the crypts are lined 
by columnar cells with basal and goblet cells 
and detached muscularis mucosa (M). (H-E, 
X400). 
Figure 9: Photomicrograph from colon section 
from rat treated with AFB1+Vit.A showing 
near to normal arrangement of the colonic 
crypts. (H-E, X400). 
Figure 10: photomicrograph from colon section 
from rat treated with AFB1+Vit.A showing 
closely packed simple tubular colonic crypts 
extending down to muscularis mucosa (M). (H-
E, X400). 
Figure 11: photomicrograph from colon section 
from rat treated with AFB1+Vit.A showing 
more or less crypt normal and lymphocytes 
infiltration (*) in the lamina propria. (H-E, 
X400).  
 
3.2 Ultrastructure Studies: 
3.2.1 Semithin Sections:  
 Histological investigation of the semithin colon sections from control and Vit. A treated rats showed 
normal histological pattern including simple columnar epithelium lining the colon with goblet cells (Figures12 & 
13).  Colon sections from rat treated with AFB1 showing goblet cell hyperplasia and abnormal colonic crypt 
(Figure 14), distorted columnar cells and colonic foci consists of sixteen crypts (Figure 15). While colon tissue 
following the administration of Vit. A to AFB1 treated rats showing improvement in the histological picture 
delineating in the well defined columnar cells and decrease in goblet cell numbers as compared with AFB1 
treated rats (Figure 16). 
3.2.2  Ultrastructure Examination: 
 The ultrastructure examination of the normal rat colon, illustrated normal columnar cells with basal 
nuclei, showed abundant microvilli projecting from the apical plasma membrane (Figure 17). Membrane bound 
vesicles were commonly seen and abundant mitochondria were seen in the supranuclear region. Both smooth and 
rough endoplasmic reticulum could also be seen through the cytoplasm. The nucleus was located in the basal 
third of the cell. Electron micrographs of the colon of rats treated with DSMO and Vit.A showed no apparent 
ultrastructure changes as compared with normal control. Transmission electron micrograph from rat colon 
treated with DSMO showing normal columnar cells with their basal nuclei and microvilli, mitochondria and 
rough endoplasmic reticulum also appeared (Figure 18) and normal colonic crypt arrangement in colon section 
from Vit.A treated rat (Figure 19). 
 Fourteen weeks after the administration of AFB1to rats, colon sections showed many histopathological 
disturbances such as goblet cell with degenerated nucleus, the nucleus of the columnar cells appeared in an 
apoptotic state, and other cells appeared with dense lysosomal vesicles (Figure 20), abnormal crypt with 
increased number of goblet cells loaded with mucus. The nuclei of columnar epithelium appeared apoptotic 
(Figure 21), aberrant crypt foci visualized with increased number of mucus secreting cells. Cryptic nuclei 
appeared in an apoptotic status (Figure 22), columnar cells nuclei with different apoptotic degrees and increased 
number of mitochondria in goblet cells as appeared in Figures (23a & b). 
 Whereas, with Vit.A treatment in AFB1-induced rats, colonic tissue appear to be normal and all 
columnar cells which were damaged due to AFB1 administration appeared to be regenerated.  Electron 
micrograph of colon section from AFB1+Vit.A  treated rat showed regained normal structure of the nuclei of the 
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columnar cells and increased numbers of mitochondria in the supranuclear region (Figure 24), with preserved 
nuclei and normal chromatin distribution (Figure 25), improved picture of the cryptic columnar cells with 
increased number of mitochondria in the suprenuclear region and decrease in goblet cell number as compared 
with AFB1 treated rats (Figure 26). 
 
 
Figure 12: Photomicrograph from control rat 
showing simple columnar epithelium lining the 
colon with goblet cells (arrow). (Toluidine blue, 
X400). 
Figure 13: Photomicrograph from colon rat 
treated wit Vit. A showing the normal structure of 
the colonic tissue. (Toluidine blue, X400). 
Figure 14: Photomicrograph from colon rat 
treated with AFB1 for fourteen weeks showing 
goblet cell hyperplasia (arrows) and abnormal 
colonic crypt. (Toluidine blue, X400). 
Figure 15: Photomicrograph of colon section from 
rat treated with AFB1 showing distorted columnar 
cells and colonic foci consists of at least sixteen 
crypts (surrounded by line). (Toluidine blue, X 
400). 
Figure 16: Photomicrograph of colon tissue from 
rat treated with AFB1+Vit. A showing 
improvement in the histological picture 
delineating in the well defined columnar cells and 
decrease in goblet cell (arrow) numbers as 
compared with AFB1 treated rats. (Toluidine 
blue, X 400). 
 
 
Figure 17: Ultrastructure micrograph from control 
rat colon showing normal columnar epithelium 
with basal nuclei and microvilli on the free 
surface (head arrow). Cells rich in mitochondria 
in the apical part of the cell. (EM, X 6000). 
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Figure 18: Photmicrograph from rat colon treated 
with DSMO showing normal columnar cells with 
their basal nuclei and microvilli, mitochondria 
(head arrows) and rough endoplasmic reticulum 
(arrow) also appeared. (EM, X 6000). 
 
Figure 19:  Transmission electron micrograph of 
colon tissue from rat treated with Vit. A showing 
normal colonic crypt arrangement with large 
number of mitochondria (head arrows) in the 
supranuclear region. (EM, X8000). 
 
 
Figure 20: Electron microscopic micrograph from 
colon rat treated with AFB1 showing goblet cell 
with degenerated nucleus (thin arrow), and the 
nucleus of the columnar cells appeared in an 
apoptotic state (thick arrow), another cell with 
dense lysosomal vesicles (head arrows). (EM, 
X5000) 
Figure 21: An electron micrograph of colon 
section from rat treated with AFB1 showing 
abnormal crypt with increased number of goblet 
cells loaded with mucus (*) and its lumen is 
obstructed. The nuclei of columnar epithelium 
appeared apoptotic (arrows). (EM, X 4000). 
Figure 22: Electron micrograph of colon section 
of rats treated with AFB1 showing aberrant crypt 
foci with increased number of mucus secreting 
cells. Cryptic nuclei appeared in an apoptotic 
(arrows) status with incommodious lumen. (EM, 
X 4000). 
Figure 23a & b: Electron micrographs of colon 
section of rats treated with AFB1 showing 
columnar cells nuclei with different apoptotic 
degrees (arrows) and increase numbers of 
mitochondria in Goblet cells respectively. (EM, X 
6000). 
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Figure 24: Electron micrograph of colon section 
from AFB1+Vit.A treated rat showing regained 
normal nuclei structure of the columnar 
epithelium, increased numbers of mitochondria 
(head arrows) in the supranuclear region. (X 
12000).  
Figure 25: An electron micrograph of colon tissue 
from rat treated with AFB1+vit. A showing 
improved histological picture of the columnar 
cells with preserved nuclei (arrows) and normal 
chromatin distribution. (X4000). 
Figure 26: Transmission electron micrograph of 
colon tissue from rat treated with AFB1+Vit.A 
showing improved picture of the cryptic columnar 
cells with increased number of mitochondria in 
the supranuclear region and decrease in goblet 
cell number (G) as compared with AFB1 treated 
rats (X 5000). 
 
3.3 Histochemical Studies: 
Colon sections from control, DSMO and Vit.A treated rats showed the normal distribution of mucous 
granules (Figures 27& 28). Colon sections from AFB1 treated rats revealed an increase in mucous positive 
material scattered in the lining cells (Figure 29). On the other hand, colon sections from AFB1+Vit. A showed 
decrease in mucous granule distribution (Figure 30) as compared with colon sections from AFB1 administered 
rats.  
 
3.4 Immunohistochemical Investigations:  
1) Bcl-2 
 Sections of colon of control and Vit A treated rats stained immunohistochemically for Bcl-2 delineated 
the normal distribution of Bcl-2 (Figure31 &32). On the other hand section in colon from rats received AFB1, 
showing increase in Bcl-2 distribution in colonic tissue (Figure33). Colon sections of rats treated with AFB1+Vit 
A showed normal structure of (Figure 34). 
 
2) Transforming growth factor-α: 
 Sections of colon of control and DSMO treated rats stained for TGF-α revealed normal distribution in 
columnar cells of colon (Figure 35 & 36). Augmentation of positive staining with the anti-TGF-α a antibody was 
seen in the columnar and goblet cells of the colon from rats received AFB1and the strongest reaction confined to 
the cytoplasm (Figure 37). Sections in rat colon treated with AFB1+Vit.A revealed near to normal distribution in 
TGF-α in colonic cells (Figure 38).  
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Figure 27: Photomicrograph of colon section of 
control rat showing the normal distribution of 
mucous in the colon tissue.  
Figure 28: Photomicrograph of colon section of 
DSMO administered rat showing the normal 
distribution of mucous granules.  
Figure 29: Photomicrograph of colon section from 
rat treated with AFB1 for 14 weeks showing 
augmentation in mucous granules in the goblet 
cells, which may be as a result of the hyperplasia 
of goblet cells and due to the increased rate of 
production of mucous. 
Figure 30: Photomicrograph of colon section from 
rat after the administration of AFB1+Vit.A 
showing decrease in mucin granules as compared 
with AFB1 administered rat (Alcian blue P.A.S., 
X400). 
 
 
 
Figure 31: Photomicrograph of colon section from 
control rat showing the normal levels of Bcl-2 
positive columnar cells in brown 
(Immunohistochemical stain, X200).  
Figure 32: Photomicrograph of colon section from 
rat treated with Vit A showing the normal levels of 
Bcl-2 positive cells (Immunohistochemical stain, 
X200).  
Figure 33: Photomicrograph of colon section from 
rat treated with AFB1 for 14 weeks showing 
increase in Bcl-2apoptotic activity in columnar 
cells (Immunohistochemical stain, X200).  
Figure 34: Photomicrograph of colon section from 
rat treated with AFB1+Vit A showing decrease in 
Bcl-2 positive columnar cells as compared with 
AFB1 treated rat (Immunohistochemical stain, 
X200). 
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Figure 35: Photomicrograph of colon sections 
from control rat showing the normal cytoplasmic 
expression of TGF-α in the columnar cells 
(Immunohistochemical stain, X200).  
Figure 36: Photomicrograph of colon sections 
from rat treated with DSMO showing the normal 
cytoplasmic expression of TGF-α in the colonic 
tissue (Immunohistochemical stain, X200).  
Figure 37: Photomicrograph of colon sections 
from treated with AFB1 for 14 weeks showing 
increase in the expression of TGF-α in the 
cytoplasm of columnar and goblet cells 
(Immunohistochemical stain, X200).  
Figure 38: Photomicrograph from rat colon section 
treated with AFB1+Vit A showing slight decrease 
in TGF-α expression in the columnar cells as 
compared with AFB1 treated rat 
(Immunohistochemical stain, X200).  
4. Discussion 
 Colon cancer is thought to develop by multistep process in which normal crypts are initiated to form 
aberrant crypt foci (ACF) that proliferate by crypt fission to form microadenoma (MA). The MA enlarge to give 
macroscopic adenoma, adenomatous polyps, and finally adenocarcinoma [19]. The main target of AFB1 is liver 
and it undergoes transformations in hepatocytes: biotransformation to active AFB1-8,9-epoxide, which gets 
bound with DNA; irreversible hydroxylation, forming metabolites M1, P1, and Q1; reversible hydroxylation, 
forming aflatoxicol [20-22]. Aflatoxins that come into animal and human gastrointestinal systems with 
contaminated food can be mitigated by various enterosorbents [23,24]. The toxico-pathological spectrum of 
AFB1 (in a broad spectrum of vertebrates) is very wide encompassing acute toxicological effects, 
carcinogenicity, teratogenicity, genotoxicity, immunotoxicity and sometimes death [25]. The fungal metabolites 
namely mycotoxins represent the most significant contaminants of food and feed [26]. Various members of 
myoctoxins were detected in animal sera, feed and food and produced severe dangerous changes in active organs 
[27]. 
 In the present study, many histopathological changes were seen such as cell degeneration, pyknotic 
nuclei and apoptosis, which may lead to cancer.  These results are abreast to those reported by Simonich et al. 
[28] postulated that AFB1 administration increasing putative pre-neoplastic foci in the colon. Chemically 
induced ACF in rodents have been used extensively to test chemicals and diets that might prevent colorectal 
cancer, and reported the colon of albino rats after treatment with aflatoxin including presence of aberrant crypt 
foci (ACF) and increase in mucous production, which lead to adenocarcinoma. This come in accordance with 
Takayama et al. [29] who reported that ACF form before colorectal polyps and are one of the earliest changes 
seen in the colon. According to the same line, Orner et al. [30] and Gursoy et al. [31] showed that aflatoxin B1 
(AFB1)-induced preneoplastic foci of the rats liver and colon in animals and humans. The term "apoptosis" 
describes the change of morphology different from cell necrosis. Hallmarks of apoptosis include chromatin 
condensation, nuclear segmentation, cytoplasmic shrinkage, blebbing, and formation of apoptotic bodies as 
revealed by Sakai et al. [32] and Xu et al. [33]. 
 Vitamin A is controlling the differentiation program of epithelial cells in the digestive tract and 
respiratory system, skin, bone, nervous system, and immune system; and for hematopoiesis [34]. Some studies 
have shown that a vitamin A deficiency in the diets of coccidiosis-challenged broilers resulted in compromised 
immune defenses as reflected in lymphocyte profiles, oocyst shedding, and interferon- levels [35]. Hamzawy et 
al. [2] and Alpsoy et al. [36] showed that AFB1 significantly decreased the level of GSH and the activities of 
superoxide dismutase and GPx and increased level of malondialdehyde. Simultaneous supplementation with 
vit.A, C, and E restored these parameters to that of normal range. Webster et al. [37] reported that vit.A thus may 
control carcinogenesis by manipulating molecular events at the initiation stage. Enzyme concentrations in 
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intestinal and colon mucosa, and in intestinal and colon contents suggested that AFB1 may have different 
metabolites and that there may be differing susceptibilities of colon mucosa to carcinogenesis. These results 
suggest that the effect of vitamin A on the metabolism of the carcinogen, particularly on binding of AFB1 to 
cellular macromolecules, may be the mechanism by which vitamin A modifies aflatoxin's carcinogenic potential, 
influenced in part through enzymatic mechanisms [38]. Ayub and Sachan [39] delineated that Vitamin A 
supplemention in rats inhibited AFB1-DNA binding [40]. The protective effects of retinoids such as retinol, 
retinal, retinoic acid, and retinal esters on AFB1 carcinogenicity were due to inhibition of AFB1-DNA adduct 
formation by affecting the CYP45O systems resulting in less epoxide being formed [41]. Retinal had the same 
inhibitory effect on the formation of AFB1 -protein adducts [40]. Vitamin A has been shown to induce the 
activity of glutathione S-transferase, thereby enhancing the detoxification of AFB1-epoxide. On the other hand, 
vitamin A deficiency decreased glutathione S-transferase activity. Kurt et al. [42] showed that lycopene and vit.E 
administration to AFB1-induced rats were found to be protective against the damage on gastric mucosa. 
Chlorophyllin (CHL) reduced the mean number of aberrant crypt foci per colon by 63%. These results show 
CHL provide potent chemoprotection against early biochemical and late pathophysiological biomarkers of AFB1 
carcinogenesis in the rat colon as reported by Simonich et al. [28]. 
 The epithelium of the intestinal tract is covered by a layer of mucus composed predominantly of mucin 
glycoproteins that are synthesized and secreted by goblet cells [43]. The mucus layer acts as a medium for 
protection, lubrication, and transport between the luminal contents and the epithelial cells [44]. Goblet cells, 
epithelial cells, macrophages, and dendritic cells are the major cellular constituents of the innate defense system, 
and the mucus layer containing mucins represents the front line of this system [45]. Mucus is secreted by goblet 
cells throughout the gastrointestinal tract and forms a gel adherent to the mucosal surface [46]. This layer acts as 
a barrier between the luminal contents and the absorptive system of the intestine and protects the mucosal 
surface from exogenous or endogenous luminal irritants such as laxatives [47]. Changes in the properties of this 
barrier could affect the absorption of both dietary and endogenous macromolecules and ions [48].  
 Mucins are complex glycoproteins that provide the viscoelastic properties of mucus that are essential 
for protection of the alimentary canal [42]. Mucins are classified into neutral and acidic subtypes; the latter are 
further distinguished by sulfated (sulfomucins) or nonsulfated (sialomucins) groups [49]. Neutral mucins appear 
to be the predominant subtype expressed in gastric mucosa. Acidic mucins are expressed throughout the 
intestinal epithelium and dominate in the large intestine.  Administration of AFB1 for 14 weeks caused 
augmentation of mucous secretion in colon tissue. Archer et al. [19] found that there is a strong relationship 
between ACF and the increased production of mucous, while, Kurt et al. [42] delineated the increase in mucin 
secretion in stomach as a result of AFB1 administration. Consistent changes in mucus-related indexes in a 
variety of intestinal and nutritional disorders, including enteric infections, inflammatory bowel disease, colon 
cancer [50]. Mucin is the predominant secreted glycoprotein in the colon and is elaborated by most colon 
cancers. The mucin extracted from colon cancer is immunologically distinct from that in the normal colon [51] 
but the exact biochemical nature of this difference has remained elusive. Attention has also been drawn to the 
goblet cell mucin of the epithelium immediately adjacent to colon cancer in which the histochemical staining 
characteristics differ from those seen in the normal colon. However, the histological appearance of the tissue 
falls short of the criteria for malignancy, and therefore it has been termed “transitional mucosa”. Jarry et al. [52] 
showed that the proinflammatory cytokine interleukin 1 (IL-1) stimulates rapid mucin release from mucin-
secreting cell line (HT29-Cl.16E cells) in a dose-dependent manner. The ability of IL-1 to trigger mucin release 
and to up-regulate mucin expression was later confirmed in studies of perfused rat colons [53] and the colonic 
LS180 cell line [54]. Enhanced mucin release appears to be a common mechanism for the intestinal clearance of 
gut parasites [55] and is routinely mediated by cytokines produced by the TH2 subset of CD4+ T cells, which 
subsequently stimulate immunoglobulin E (IgE) production [56]. Lake et al. [57] showed that IgE mediated mast 
cell discharge of histamine enhanced the release of goblet cell mucus into the rat duodenum. 
 As vit. A administered ti AFB1-induced rats, colonic tissue showed decrease in mucous production as 
compared with AFB1 treated animals, this may be related to its antioxidant activity. Kurt et al., [42] reported that 
lycopene and vit. E administration reverse the increase in mucin secretion in gastric mucosa in AFB1 
administered rats. 
 A considerable body of evidence exists suggested that AFB1 suppresses immune function by affecting 
T-cell dependent immunity in various animal species. Studies with laboratory test species such as the mouse 
[58,59], rat [60], and rabbit [61] reinforce these findings. Immunosuppression by a toxicant can result from 
various mechanisms such as decreased protein and/or DNA synthesis, changes or loss in enzymatic activity, and 
changes in metabolism or cell cycles, which may result in apoptosis or necrosis. Immune mechanisms affected 
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by AFB1, in addition to T-cell dependent immunity, include reduced production of complement by the liver and 
decreased phagocytosis by neutrophils and macrophage activities [62,63]. Toxic effects on T-lymphocytes [63] 
and/or other lymphoid cells such as the cytotoxic T-cells and natural killer cells [64], which impair the function 
of direct or indirect killing of tumor cells, can have pronounced effects on tumorigenesis. Immunosuppression 
can result in a greater rate of tumor progression [60]. Moreover, cellular components of the immune system are 
known to produce various cytokines, which play a key role in host resistance and protection against tumor 
progression. These same cytokines, however, are involved directly in the inflammatory mechanisms that are 
initiated when various organs have been damaged by toxic assault [65].  
 Apoptosis is a specialized process of cell death that is part of the normal development of organs and 
tissue maintenance, but may also occur as a response to various environmental stimuli, indicating toxicity [66]. 
Since apoptosis can play a critical role in the development of cancer, the ability of toxins to induce apoptosis 
appears to be related to their toxicological effects [10,67,68]. Bcl-2 is a suppressor gene of apoptosis, which was 
found from follicular B cell lymphoma with t(14,18) chromosome malposition [33,96]. Orientating as 18q21, 
Bax, and Bcl-2 are homologous proteins, and Bax is an induction gene of apoptosis. Bcl-2 and Bax can exist in 
the form of homodimer and form heterodimer too. When the expression of Bax increases, the homodimer of 
Bax-Bax can induce apoptosis. When the expression of Bcl-2 increases, Bax can combine with Bcl-2 to form 
more stable heterodimers which can inhibit apoptosis. The ratio of Bcl-2/Bax can regulate apoptosis [70]. 
 The present study revealed that increase in Bcl-2 expression associated with decreased apoptosis and 
increased cell proliferation in colon tissue. Proteins in the Bcl-2 family are central regulators of programmed cell 
death, and members that inhibit apoptosis, such as Bcl-X(L) and Bcl-2, are overexpressed in many cancers and 
contribute to tumour initiation, progression and resistance to therapy [71]. Bcl-2 protein blocks a distal step in an 
evolutionarily conserved pathway for programmed cell death and apoptosis [11]. Wu et al., [72] suggested that 
long-term dietary corn oil promotes AOM-induced colon cancer development partly by inhibiting the tumor 
suppressor gene p53 mediated mitochondria-dependent apoptosis. Which leading to upregulation of Bcl-2.  
 Neoplasia of the normal colonic epithelium goes through ordered stages, first to adenomatous then to 
malignant change. Epidermal growth factor/ TGF-α receptor and TGF-α production have been individually 
detected in colon carcinomas and in numerous colon cancer cell lines [73,74]. Coexpression of TGF-α and 
epidermal growth factor receptor and growth stimulation by TGF-α has also been shown in multiple colon cancer 
cell lines, and TGF-α has been proposed as an autocrine growth factor in colon cancer. 
 AFB1 administration caused increase in TGF-α expression in rat colon tissues. TGF-α, a stimulatory 
growth factor inhibit apoptosis and member of the epidermal growth factor family, is a mediator of malignant 
progression in colorectal carcinogenesis. TGF-α expression in the rectum was higher in patients compared with 
controls and statistically significantly associated with accepted risk factors for colorectal neoplasms [75-77]. 
These findings support the potential for TGF-α as a modifiable biomarker of risk for colorectal cancer. Basic 
science evidence strongly supports a progrowth and hyperproliferative mechanism in colon carcinogenesis with 
elevated TGF-α expression in colon adenoma and adenocarcinomas [78]. Many studies suggested that TGF-α 
may be a potential marker of colorectal cancer risk [78,79]. 
 Administration of vit. A, resulted in inhibition of Bcl-2 and TGF-α expressions in rat colon. This come 
in accordance with a research from Hong et al. [80] who has shown that dietary fish oil increases apoptosis by 
down regulating Bcl-2 expression in rat colon. Again, Kauntz et al. [81] investigated the potential of silibinin (a 
flavonolignan substance) as a chemopreventive agent in rat colon carcinogenesis. Mechanisms involved in 
silibinin-induced apoptosis included the downregulation of the anti-apoptotic protein Bcl-2 and upregulation of 
the pro-apoptotic protein Bax, inverting the Bcl-2/Bax ratio.  
5. Conclusion: 
 To our knowledge, this is the first prospective investigation, which has assessed the association between 
vitamin A and Bcl-2 and TGF-α expression in colon cancer. Present data concluded that the immunomodulatory 
mechanism of action of vitamin A in enhancing cell apoptosis, which is inhibited by Bcl-2 and TGF-α in AFB1 
induced rats, and as a result enhancing cancerous cell death. These results may open up a new way for the 
treatment of colon cancer, by adding it to our daily diets. 
 The present investigation delineated that histopathological, ultrastructure, histochemical and 
immunohistochemical damage is attributed to the environmental pollution of food and feeds by fungi and their 
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toxins. Therefore, sanitary care must be conducted during all steps of feed and food processing and production. 
Farmers and food manufacturers, whose work related to contact with animals must provide them with awareness 
through workshops and health bulletins to prevent such pollution. This will lead to maintain human health and 
keep livestock sources safe. 
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